Octagon Capital Advisors LP 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 5:42 pm Purchase |
2024-12-31 | 13G | Dianthus Therapeutics, Inc. DNTH |
Octagon Capital Advisors LP | 2,110,167 7.100% |
363,500 (+20.81%) |
Filing |
| 2024-10-11 4:02 pm Purchase |
2024-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH |
Octagon Capital Advisors LP | 1,746,667 6.000% |
1,746,667 (New Position) |
Filing |